2017 annual financial data
Fate Therapeutics 2017 Operating margin
Direct answer
Operating margin was -1,025.94%.
Operating income was -42,125,000 USD and net income was -42,952,000 USD.
Operating cash flow was -36,905,000 USD.
Get free Fate Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,106,000 USD
- Operating income
- -42,125,000 USD
- Net income
- -42,952,000 USD
- Operating cash flow
- -36,905,000 USD